; (3) an opium derivative as described in section 1308.11(c) of such title (or successor regulations); (4) a stimulant as described in section 1308.11(f) or 1308.12(d) of such title (or successor regulations); and (5) a fentanyl-related substance as described in section 1308.11(h) of such title (or successor regulations). .